Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-29
2000-03-21
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514247, 514256, A61K 31505
Patent
active
060403101
ABSTRACT:
A method of treating conditions associated with neuropeptide Y which comprises administering a compound of the formula ##STR1## to a mammalian subject in need of such treatment.
REFERENCES:
patent: 5403843 (1995-04-01), Akimoto et al.
patent: 5576337 (1996-11-01), Bruns et al.
patent: 5602024 (1997-02-01), Gerald et al.
S. Ordzhonikidze All-Union Research Institute for Pharmaceutical Chemistry (VNIKhFI), Moscow. Translated from Khimiko-farmatsevticheskii Zhurnal, vol. 22, No. 2, pp. 185-191, Feb., 1988.
S. Ordzhonikidze All-Union Scientific-Research Institute for Pharmaceutical Chemistry, Moscow. Translated from Khimiko-farmatsevticheskii Zhurnal, vol. 7, No. 3, pp. 19-24, Mar., 1973.
S. Ordzhonikidze All-Union Scientific Pharmaceutical Chemistry Research Institute, Moscow. Translated from Khimikofarmatsevticheskii Zhurnal, vol. 8, No. 1, pp. 14-17, Jan., 1974.
Dow Robert L.
Tate Bonnie F.
Benson Gregg C.
Brokke Mervin E.
Delacroix-Muirheid Cybille
Jones Dwayne C.
Pfizer Inc.
LandOfFree
4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730544